{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:56:16Z","timestamp":1792079776841,"version":"4.4.0"},"reference-count":206,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-024-00568-0","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:03:56Z","timestamp":1730952236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Rett syndrome"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1808-0646","authenticated-orcid":false,"given":"Wendy A.","family":"Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Percy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Neul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart R.","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-5527","authenticated-orcid":false,"given":"Lucas","family":"Pozzo-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmeen K.","family":"Issar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruria","family":"Ben-Zeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aglaia","family":"Vignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"568_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","volume":"148","author":"CL Laurvick","year":"2006","unstructured":"Laurvick, C. L. et al. Rett syndrome in Australia: a review of the epidemiology. J. Pediatr. 148, 347\u2013352 (2006).","journal-title":"J. Pediatr."},{"key":"568_CR2","first-page":"723","volume":"116","author":"A Rett","year":"1966","unstructured":"Rett, A. On a unusual brain atrophy syndrome in hyperammonemia in childhood [German]. Wien. Med. Wochenschr. 116, 723\u2013726 (1966).","journal-title":"Wien. Med. Wochenschr."},{"key":"568_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ana.410140412","volume":"14","author":"B Hagberg","year":"1983","unstructured":"Hagberg, B., Aicardi, J., Dias, K. & Ramos, O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett\u2019s syndrome: report of 35 cases. Ann. Neurol. 14, 471\u2013479 (1983).","journal-title":"Ann. Neurol."},{"key":"568_CR4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","volume":"68","author":"JL Neul","year":"2010","unstructured":"Neul, J. L. et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68, 944\u2013950 (2010).","journal-title":"Ann. Neurol."},{"key":"568_CR5","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","volume":"70","author":"JL Neul","year":"2008","unstructured":"Neul, J. L. et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 70, 1313\u20131321 (2008).","journal-title":"Neurology"},{"key":"568_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185\u2013188 (1999).","journal-title":"Nat. Genet."},{"key":"568_CR7","first-page":"49","volume":"3","author":"AK Percy","year":"2018","unstructured":"Percy, A. K. et al. When Rett syndrome is due to genes other than MECP2. Transl. Sci. Rare Dis. 3, 49\u201353 (2018).","journal-title":"Transl. Sci. Rare Dis."},{"key":"568_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/gim.2016.42","volume":"19","author":"SA Sajan","year":"2017","unstructured":"Sajan, S. A. et al. Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2. Genet. Med. 19, 13\u201319 (2017).","journal-title":"Genet. Med."},{"key":"568_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10803-013-1902-z","volume":"44","author":"B Suter","year":"2014","unstructured":"Suter, B., Treadwell-Deering, D., Zoghbi, H. Y., Glaze, D. G. & Neul, J. L. Brief report: MECP2 mutations in people without Rett syndrome. J. Autism Dev. Disord. 44, 703\u2013711 (2014).","journal-title":"J. Autism Dev. Disord."},{"key":"568_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.pediatrneurol.2015.06.003","volume":"53","author":"DC Tarquinio","year":"2015","unstructured":"Tarquinio, D. C. et al. The changing face of survival in Rett syndrome and MECP2-related disorders. Pediatr. Neurol. 53, 402\u2013411 (2015).","journal-title":"Pediatr. Neurol."},{"key":"568_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.b.32707","volume":"180","author":"JL Neul","year":"2019","unstructured":"Neul, J. L. et al. The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. Am. J. Med. Genet. B Neuropsychiatr. Genet. 180, 55\u201367 (2019).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"568_CR12","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jmb.2019.10.004","volume":"432","author":"R Tillotson","year":"2020","unstructured":"Tillotson, R. & Bird, A. The molecular basis of MeCP2 function in the brain. J. Mol. Biol. 432, 1602\u20131623 (2020).","journal-title":"J. Mol. Biol."},{"key":"568_CR13","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224\u20131229 (2008).","journal-title":"Science"},{"key":"568_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jnc.15331","volume":"159","author":"SR D\u2019Mello 3rd","year":"2021","unstructured":"D\u2019Mello, S. R. 3rd MECP2 and the biology of MECP2 duplication syndrome. J. Neurochem. 159, 29\u201360 (2021).","journal-title":"J. Neurochem."},{"key":"568_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","volume":"88","author":"X Nan","year":"1997","unstructured":"Nan, X., Campoy, F. J. & Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471\u2013481 (1997).","journal-title":"Cell"},{"key":"568_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","volume":"37","author":"PJ Skene","year":"2010","unstructured":"Skene, P. J. et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457\u2013468 (2010).","journal-title":"Mol. Cell"},{"key":"568_CR17","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.cell.2012.11.022","volume":"151","author":"M Mell\u00e9n","year":"2012","unstructured":"Mell\u00e9n, M., Ayata, P., Dewell, S., Kriaucionis, S. & Heintz, N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417\u20131430 (2012).","journal-title":"Cell"},{"key":"568_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nn.2275","volume":"12","author":"N Ballas","year":"2009","unstructured":"Ballas, N., Lioy, D. T., Grunseich, C. & Mandel, G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci. 12, 311\u2013317 (2009).","journal-title":"Nat. Neurosci."},{"key":"568_CR19","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0324-09.2009","volume":"29","author":"I Maezawa","year":"2009","unstructured":"Maezawa, I., Swanberg, S., Harvey, D., LaSalle, J. M. & Jin, L. W. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci. 29, 5051\u20135061 (2009).","journal-title":"J. Neurosci."},{"key":"568_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2020-000731","volume":"4","author":"C Fu","year":"2020","unstructured":"Fu, C. et al. Multisystem comorbidities in classic Rett syndrome: a scoping review. BMJ Paediatr. Open. 4, e000731 (2020).","journal-title":"BMJ Paediatr. Open."},{"key":"568_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2020-000717","volume":"4","author":"C Fu","year":"2020","unstructured":"Fu, C. et al. Consensus guidelines on managing Rett syndrome across the lifespan. BMJ Paediatr. Open. 4, e000717 (2020).","journal-title":"BMJ Paediatr. Open."},{"key":"568_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.braindev.2018.08.008","volume":"41","author":"CB Buchanan","year":"2019","unstructured":"Buchanan, C. B. et al. Behavioral profiles in Rett syndrome: data from the Natural History Study. Brain Dev. 41, 123\u2013134 (2019).","journal-title":"Brain Dev."},{"key":"568_CR23","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/WNL.0b013e3181d6b852","volume":"74","author":"DG Glaze","year":"2010","unstructured":"Glaze, D. G. et al. Epilepsy and the natural history of Rett syndrome. Neurology 74, 909\u2013912 (2010).","journal-title":"Neurology"},{"key":"568_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0387-7604(12)80200-2","volume":"12","author":"DJ Harrison","year":"1990","unstructured":"Harrison, D. J. & Webb, P. J. Scoliosis in the Rett syndrome: natural history and treatment. Brain Dev. 12, 154\u2013156 (1990).","journal-title":"Brain Dev."},{"key":"568_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1866-1955-6-20","volume":"6","author":"JL Neul","year":"2014","unstructured":"Neul, J. L. et al. Developmental delay in Rett syndrome: data from the Natural History Study. J. Neurodev. Disord. 6, 20 (2014).","journal-title":"J. Neurodev. Disord."},{"key":"568_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ana.22154","volume":"68","author":"AK Percy","year":"2010","unstructured":"Percy, A. K. et al. Rett syndrome diagnostic criteria: lessons from the Natural History Study. Ann. Neurol. 68, 951\u2013955 (2010).","journal-title":"Ann. Neurol."},{"key":"568_CR27","doi-asserted-by":"publisher","first-page":"e2594","DOI":"10.1212\/WNL.0000000000007560","volume":"92","author":"JL Stallworth","year":"2019","unstructured":"Stallworth, J. L. et al. Hand stereotypies: lessons from the Rett Syndrome Natural History Study. Neurology 92, e2594\u2013e2603 (2019).","journal-title":"Neurology"},{"key":"568_CR28","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","volume":"29","author":"JL Neul","year":"2023","unstructured":"Neul, J. L. et al. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nat. Med. 29, 1468\u20131475 (2023).","journal-title":"Nat. Med."},{"key":"568_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02169-6","volume":"12","author":"U Petriti","year":"2023","unstructured":"Petriti, U., Dudman, D. C., Scosyrev, E. & Lopez-Leon, S. Global prevalence of Rett syndrome: systematic review and meta-analysis. Syst. Rev. 12, 5 (2023).","journal-title":"Syst. Rev."},{"key":"568_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0387-7604(85)80048-6","volume":"7","author":"B Hagberg","year":"1985","unstructured":"Hagberg, B., Gouti\u00e8res, F., Hanefeld, F., Rett, A. & Wilson, J. Rett syndrome: criteria for inclusion and exclusion. Brain Dev. 7, 372\u2013373 (1985).","journal-title":"Brain Dev."},{"key":"568_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1542\/peds.91.2.445","volume":"91","author":"CA Kozinetz","year":"1993","unstructured":"Kozinetz, C. A. et al. Epidemiology of Rett syndrome: a population-based registry. Pediatrics 91, 445\u2013450 (1993).","journal-title":"Pediatrics"},{"key":"568_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1203\/PDR.0b013e3182242461","volume":"70","author":"S Fehr","year":"2011","unstructured":"Fehr, S. et al. Trends in the diagnosis of Rett syndrome in Australia. Pediatr. Res. 70, 313\u2013319 (2011).","journal-title":"Pediatr. Res."},{"key":"568_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000369494","volume":"44","author":"A Sarajlija","year":"2015","unstructured":"Sarajlija, A. et al. Epidemiology of Rett syndrome in Serbia: prevalence, incidence and survival. Neuroepidemiology 44, 1\u20135 (2015).","journal-title":"Neuroepidemiology"},{"key":"568_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pediatrneurol.2005.10.013","volume":"34","author":"T Bienvenu","year":"2006","unstructured":"Bienvenu, T. et al. The incidence of Rett syndrome in France. Pediatr. Neurol. 34, 372\u2013375 (2006).","journal-title":"Pediatr. Neurol."},{"key":"568_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-87","volume":"9","author":"A Anderson","year":"2014","unstructured":"Anderson, A., Wong, K., Jacoby, P., Downs, J. & Leonard, H. Twenty years of surveillance in Rett syndrome: what does this tell us? Orphanet J. Rare Dis. 9, 87 (2014).","journal-title":"Orphanet J. Rare Dis."},{"issue":"Suppl 1","key":"568_CR36","first-page":"71","volume":"6","author":"AM Kerr","year":"1997","unstructured":"Kerr, A. M., Armstrong, D. D., Prescott, R. J., Doyle, D. & Kearney, D. L. Rett syndrome: analysis of deaths in the British survey. Eur. Child. Adolesc. Psychiatry 6 (Suppl. 1), 71\u201374 (1997).","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"568_CR37","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/nar\/gkh349","volume":"32","author":"S Kriaucionis","year":"2004","unstructured":"Kriaucionis, S. & Bird, A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32, 1818\u20131823 (2004).","journal-title":"Nucleic Acids Res."},{"key":"568_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng1327","volume":"36","author":"GN Mnatzakanian","year":"2004","unstructured":"Mnatzakanian, G. N. et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet. 36, 339\u2013341 (2004).","journal-title":"Nat. Genet."},{"key":"568_CR39","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.3390\/ijms20153813","volume":"20","author":"U Kahanovitch","year":"2019","unstructured":"Kahanovitch, U., Patterson, K. C., Hernandez, R. & Olsen, M. L. Glial dysfunction in MeCP2 deficiency models: implications for Rett syndrome. Int. J. Mol. Sci. 20, 3816 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"568_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1021\/acschemneuro.7b00346","volume":"9","author":"WA Gold","year":"2018","unstructured":"Gold, W. A., Krishnarajy, R., Ellaway, C. & Christodoulou, J. Rett syndrome: a genetic update and clinical review focusing on comorbidities. ACS Chem. Neurosci. 9, 167\u2013176 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"568_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63725","volume":"194","author":"M Abbott","year":"2024","unstructured":"Abbott, M. et al. Rett syndrome diagnostic odyssey: limitations of NextGen sequencing. Am. J. Med. Genet. A 194, e63725 (2024).","journal-title":"Am. J. Med. Genet. A"},{"key":"568_CR42","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.ajhg.2024.04.018","volume":"111","author":"AT Pagnamenta","year":"2024","unstructured":"Pagnamenta, A. T. et al. The impact of inversions across 33,924 families with rare disease from a national genome sequencing project. Am. J. Hum. Genet. 111, 1140\u20131164 (2024).","journal-title":"Am. J. Hum. Genet."},{"key":"568_CR43","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1212\/01.wnl.0000304752.50773.ec","volume":"70","author":"A Bebbington","year":"2008","unstructured":"Bebbington, A. et al. Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology 70, 868\u2013875 (2008).","journal-title":"Neurology"},{"key":"568_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","volume":"51","author":"VA Cuddapah","year":"2014","unstructured":"Cuddapah, V. A. et al. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J. Med. Genet. 51, 152\u2013158 (2014).","journal-title":"J. Med. Genet."},{"key":"568_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jmg.2006.045260","volume":"44","author":"H Archer","year":"2007","unstructured":"Archer, H. et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J. Med. Genet. 44, 148\u2013152 (2007).","journal-title":"J. Med. Genet."},{"key":"568_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48385-w","volume":"9","author":"C Xiol","year":"2019","unstructured":"Xiol, C. et al. X chromosome inactivation does not necessarily determine the severity of the phenotype in Rett syndrome patients. Sci. Rep. 9, 11983 (2019).","journal-title":"Sci. Rep."},{"key":"568_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1917","volume":"10","author":"X Fang","year":"2022","unstructured":"Fang, X. et al. Analysis of X-inactivation status in a Rett syndrome natural history study cohort. Mol. Genet. Genom. Med. 10, e1917 (2022).","journal-title":"Mol. Genet. Genom. Med."},{"key":"568_CR48","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1212\/01.wnl.0000304086.75913.b2","volume":"70","author":"J Nectoux","year":"2008","unstructured":"Nectoux, J. et al. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome. Neurology 70, 2145\u20132151 (2008).","journal-title":"Neurology"},{"key":"568_CR49","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1212\/01.wnl.0000345664.72220.6a","volume":"72","author":"BB Zeev","year":"2009","unstructured":"Zeev, B. B. et al. The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome. Neurology 72, 1242\u20131247 (2009).","journal-title":"Neurology"},{"key":"568_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.brainresbull.2011.08.019","volume":"86","author":"CJ Hong","year":"2011","unstructured":"Hong, C. J., Liou, Y. J. & Tsai, S. J. Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res. Bull. 86, 287\u2013297 (2011).","journal-title":"Brain Res. Bull."},{"key":"568_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-O","volume":"69","author":"JD Lewis","year":"1992","unstructured":"Lewis, J. D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905\u2013914 (1992).","journal-title":"Cell"},{"key":"568_CR52","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nn.3434","volume":"16","author":"MJ Lyst","year":"2013","unstructured":"Lyst, M. J. et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR\/SMRT co-repressor. Nat. Neurosci. 16, 898\u2013902 (2013).","journal-title":"Nat. Neurosci."},{"key":"568_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006793","volume":"13","author":"S Lagger","year":"2017","unstructured":"Lagger, S. et al. MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain. PLoS Genet. 13, e1006793 (2017).","journal-title":"PLoS Genet."},{"key":"568_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrg3897","volume":"16","author":"MJ Lyst","year":"2015","unstructured":"Lyst, M. J. & Bird, A. Rett syndrome: a complex disorder with simple roots. Nat. Rev. Genet. 16, 261\u2013275 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"568_CR55","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nature24058","volume":"550","author":"R Tillotson","year":"2017","unstructured":"Tillotson, R. et al. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Nature 550, 398\u2013401 (2017).","journal-title":"Nature"},{"key":"568_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","volume":"49","author":"Q Chang","year":"2006","unstructured":"Chang, Q., Khare, G., Dani, V., Nelson, S. & Jaenisch, R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49, 341\u2013348 (2006).","journal-title":"Neuron"},{"key":"568_CR57","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.1086446","volume":"302","author":"WG Chen","year":"2003","unstructured":"Chen, W. G. et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885\u2013889 (2003).","journal-title":"Science"},{"key":"568_CR58","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/hmg\/ddm007","volume":"16","author":"V Deng","year":"2007","unstructured":"Deng, V. et al. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum. Mol. Genet. 16, 640\u2013650 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"568_CR59","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.3390\/ijms231911125","volume":"23","author":"F Haase","year":"2022","unstructured":"Haase, F., Singh, R., Gloss, B., Tam, P. & Gold, W. Meta-analysis identifies BDNF and novel common genes differently altered in cross-species models of Rett syndrome. Int. J. Mol. Sci. 23, 11125 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"568_CR60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/nen.0b013e3180302078","volume":"66","author":"M Itoh","year":"2007","unstructured":"Itoh, M. et al. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. J. Neuropathol. Exp. Neurol. 66, 117\u2013123 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"568_CR61","doi-asserted-by":"publisher","first-page":"15114","DOI":"10.1073\/pnas.1618737114","volume":"113","author":"B Kinde","year":"2016","unstructured":"Kinde, B., Wu, D. Y., Greenberg, M. E. & Gabel, H. W. DNA methylation in the gene body influences MeCP2-mediated gene repression. Proc. Natl Acad. Sci. USA 113, 15114\u201315119 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"568_CR62","doi-asserted-by":"publisher","first-page":"15536","DOI":"10.1073\/pnas.242566899","volume":"99","author":"M Tudor","year":"2002","unstructured":"Tudor, M., Akbarian, S., Chen, R. Z. & Jaenisch, R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA 99, 15536\u201315541 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"568_CR63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneurol.2016.186","volume":"13","author":"H Leonard","year":"2017","unstructured":"Leonard, H., Cobb, S. & Downs, J. Clinical and biological progress over 50 years in Rett syndrome. Nat. Rev. Neurol. 13, 37\u201351 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"568_CR64","doi-asserted-by":"publisher","DOI":"10.4161\/rdis.27265","volume":"1","author":"MJ Justice","year":"2013","unstructured":"Justice, M. J., Buchovecky, C. M., Kyle, S. M. & Djukic, A. A role for metabolism in Rett syndrome pathogenesis: new clinical findings and potential treatment targets. Rare Dis. 1, e27265 (2013).","journal-title":"Rare Dis."},{"key":"568_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104834","volume":"9","author":"M Segatto","year":"2014","unstructured":"Segatto, M. et al. Cholesterol metabolism is altered in Rett syndrome: a study on plasma and primary cultured fibroblasts derived from patients. PLoS ONE 9, e104834 (2014).","journal-title":"PLoS ONE"},{"key":"568_CR66","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.febslet.2013.05.042","volume":"587","author":"C Sticozzi","year":"2013","unstructured":"Sticozzi, C. et al. Scavenger receptor B1 post-translational modifications in Rett syndrome. FEBS Lett. 587, 2199\u20132204 (2013).","journal-title":"FEBS Lett."},{"key":"568_CR67","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1073\/pnas.1311141111","volume":"111","author":"OS Khwaja","year":"2014","unstructured":"Khwaja, O. S. et al. Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc. Natl Acad. Sci. USA 111, 4596\u20134601 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"568_CR68","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ng.2714","volume":"45","author":"CM Buchovecky","year":"2013","unstructured":"Buchovecky, C. M. et al. A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nat. Genet. 45, 1013\u20131020 (2013).","journal-title":"Nat. Genet."},{"key":"568_CR69","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s41593-018-0270-6","volume":"21","author":"W Renthal","year":"2018","unstructured":"Renthal, W. et al. Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing. Nat. Neurosci. 21, 1670\u20131679 (2018).","journal-title":"Nat. Neurosci."},{"key":"568_CR70","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1086\/444549","volume":"77","author":"H Van Esch","year":"2005","unstructured":"Van Esch, H. et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77, 442\u2013453 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"568_CR71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312757121","volume":"121","author":"A Zito","year":"2024","unstructured":"Zito, A. & Lee, J. T. Variable expression of MECP2, CDKL5, and FMR1 in the human brain: implications for gene restorative therapies. Proc. Natl Acad. Sci. USA 121, e2312757121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"568_CR72","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/brain\/awy323","volume":"142","author":"A Banerjee","year":"2019","unstructured":"Banerjee, A., Miller, M. T., Li, K., Sur, M. & Kaufmann, W. E. Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder. Brain 142, 239\u2013248 (2019).","journal-title":"Brain"},{"issue":"Suppl 1","key":"568_CR73","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.braindev.2004.10.008","volume":"27","author":"WE Kaufmann","year":"2005","unstructured":"Kaufmann, W. E., Johnston, M. V. & Blue, M. E. MeCP2 expression and function during brain development: implications for Rett syndrome\u2019s pathogenesis and clinical evolution. Brain Dev. 27 (Suppl. 1), S77\u2013s87 (2005).","journal-title":"Brain Dev."},{"key":"568_CR74","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/21678707.2016.1229181","volume":"4","author":"WE Kaufmann","year":"2016","unstructured":"Kaufmann, W. E., Stallworth, J. L., Everman, D. B. & Skinner, S. A. Neurobiologically-based treatments in Rett syndrome: opportunities and challenges. Expert. Opin. Orphan Drugs 4, 1043\u20131055 (2016).","journal-title":"Expert. Opin. Orphan Drugs"},{"key":"568_CR75","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/85906","volume":"27","author":"RZ Chen","year":"2001","unstructured":"Chen, R. Z., Akbarian, S., Tudor, M. & Jaenisch, R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27, 327\u2013331 (2001).","journal-title":"Nat. Genet."},{"key":"568_CR76","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","volume":"27","author":"J Guy","year":"2001","unstructured":"Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322\u2013326 (2001).","journal-title":"Nat. Genet."},{"key":"568_CR77","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.cell.2017.04.035","volume":"169","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Modeling Rett syndrome using TALEN-edited MECP2 mutant cynomolgus monkeys. Cell 169, 945\u2013955.e10 (2017).","journal-title":"Cell"},{"key":"568_CR78","first-page":"4389","volume":"25","author":"PD Ross","year":"2016","unstructured":"Ross, P. D. et al. Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes. Hum. Mol. Genet. 25, 4389\u20134404 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"568_CR79","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pediatrneurol.2017.01.032","volume":"70","author":"JT Killian","year":"2017","unstructured":"Killian, J. T. et al. Scoliosis in Rett syndrome: progression, comorbidities, and predictors. Pediatr. Neurol. 70, 20\u201325 (2017).","journal-title":"Pediatr. Neurol."},{"key":"568_CR80","first-page":"5","volume":"2012","author":"W Li","year":"2012","unstructured":"Li, W. & Pozzo-Miller, L. Beyond widespread Mecp2 deletions to model Rett syndrome: conditional spatio-temporal knockout, single-point mutations and transgenic rescue mice. Autism Open. Access. 2012, 5 (2012).","journal-title":"Autism Open. Access."},{"key":"568_CR81","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature12348","volume":"499","author":"DH Ebert","year":"2013","unstructured":"Ebert, D. H. et al. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499, 341\u2013345 (2013).","journal-title":"Nature"},{"key":"568_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","volume":"52","author":"Z Zhou","year":"2006","unstructured":"Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255\u2013269 (2006).","journal-title":"Neuron"},{"key":"568_CR83","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature10214","volume":"475","author":"DT Lioy","year":"2011","unstructured":"Lioy, D. T. et al. A role for glia in the progression of Rett\u2019s syndrome. Nature 475, 497\u2013500 (2011).","journal-title":"Nature"},{"key":"568_CR84","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.21562","volume":"65","author":"A Horsk\u00e1","year":"2009","unstructured":"Horsk\u00e1, A. et al. Brain metabolism in Rett syndrome: age, clinical, and genotype correlations. Ann. Neurol. 65, 90\u201397 (2009).","journal-title":"Ann. Neurol."},{"key":"568_CR85","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jnen\/59.10.889","volume":"59","author":"JD Lipani","year":"2000","unstructured":"Lipani, J. D., Bhattacharjee, M. B., Corey, D. M. & Lee, D. A. Reduced nerve growth factor in Rett syndrome postmortem brain tissue. J. Neuropathol. Exp. Neurol. 59, 889\u2013895 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"568_CR86","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1006\/nbdi.2001.0428","volume":"8","author":"C Colantuoni","year":"2001","unstructured":"Colantuoni, C. et al. Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol. Dis. 8, 847\u2013865 (2001).","journal-title":"Neurobiol. Dis."},{"key":"568_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000157","volume":"2","author":"A Viola","year":"2007","unstructured":"Viola, A., Saywell, V., Villard, L., Cozzone, P. J. & Lutz, N. W. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model. PLoS ONE 2, e157 (2007).","journal-title":"PLoS ONE"},{"key":"568_CR88","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","volume":"30","author":"I Maezawa","year":"2010","unstructured":"Maezawa, I. & Jin, L. W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci. 30, 5346\u20135356 (2010).","journal-title":"J. Neurosci."},{"key":"568_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2013.09.002","volume":"265","author":"CM O\u2019Driscoll","year":"2013","unstructured":"O\u2019Driscoll, C. M., Kaufmann, W. E. & Bressler, J. P. MeCP2 deficiency enhances glutamate release through NF-\u03baB signaling in myeloid derived cells. J. Neuroimmunol. 265, 61\u201367 (2013).","journal-title":"J. Neuroimmunol."},{"key":"568_CR90","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature10907","volume":"484","author":"NC Derecki","year":"2012","unstructured":"Derecki, N. C. et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105\u2013109 (2012).","journal-title":"Nature"},{"key":"568_CR91","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature14444","volume":"521","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Wild-type microglia do not reverse pathology in mouse models of Rett syndrome. Nature 521, E1\u2013E4 (2015).","journal-title":"Nature"},{"key":"568_CR92","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3174\/ajnr.A0857","volume":"29","author":"JC Carter","year":"2008","unstructured":"Carter, J. C. et al. Selective cerebral volume reduction in Rett syndrome: a multiple-approach MR imaging study. AJNR Am. J. Neuroradiol. 29, 436\u2013441 (2008).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"568_CR93","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3174\/ajnr.A1792","volume":"31","author":"A Mahmood","year":"2010","unstructured":"Mahmood, A. et al. White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations. AJNR Am. J. Neuroradiol. 31, 295\u2013299 (2010).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"568_CR94","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1242\/dmm.011007","volume":"5","author":"DM Katz","year":"2012","unstructured":"Katz, D. M. et al. Preclinical research in Rett syndrome: setting the foundation for translational success. Dis. Model. Mech. 5, 733\u2013745 (2012).","journal-title":"Dis. Model. Mech."},{"key":"568_CR95","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1113\/JP274450","volume":"595","author":"X Xu","year":"2017","unstructured":"Xu, X. & Pozzo-Miller, L. EEA1 restores homeostatic synaptic plasticity in hippocampal neurons from Rett syndrome mice. J. Physiol. 595, 5699\u20135712 (2017).","journal-title":"J. Physiol."},{"key":"568_CR96","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143\u20131147 (2007).","journal-title":"Science"},{"key":"568_CR97","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/hmg\/ddt421","volume":"23","author":"M Lang","year":"2014","unstructured":"Lang, M. et al. Rescue of behavioral and EEG deficits in male and female Mecp2-deficient mice by delayed Mecp2 gene reactivation. Hum. Mol. Genet. 23, 303\u2013318 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"568_CR98","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/brain\/aws096","volume":"135","author":"L Robinson","year":"2012","unstructured":"Robinson, L. et al. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 135, 2699\u20132710 (2012).","journal-title":"Brain"},{"key":"568_CR99","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1093\/hmg\/dds208","volume":"21","author":"H Cheval","year":"2012","unstructured":"Cheval, H. et al. Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows. Hum. Mol. Genet. 21, 3806\u20133814 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"568_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0545-5","volume":"11","author":"F Ehrhart","year":"2016","unstructured":"Ehrhart, F. et al. Rett syndrome \u2013 biological pathways leading from MECP2 to disorder phenotypes. Orphanet J. Rare Dis. 11, 158 (2016).","journal-title":"Orphanet J. Rare Dis."},{"key":"568_CR101","doi-asserted-by":"publisher","first-page":"21966","DOI":"10.1073\/pnas.0912257106","volume":"106","author":"RC Samaco","year":"2009","unstructured":"Samaco, R. C. et al. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc. Natl Acad. Sci. USA 106, 21966\u201321971 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"568_CR102","doi-asserted-by":"publisher","first-page":"C508","DOI":"10.1152\/ajpcell.00035.2014","volume":"307","author":"MF Oginsky","year":"2014","unstructured":"Oginsky, M. F., Cui, N., Zhong, W., Johnson, C. M. & Jiang, C. Alterations in the cholinergic system of brain stem neurons in a mouse model of Rett syndrome. Am. J. Physiol. Cell Physiol. 307, C508\u2013C520 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"568_CR103","doi-asserted-by":"publisher","first-page":"ENEURO.0134-19.","DOI":"10.1523\/ENEURO.0134-19.2019","volume":"6","author":"EC Ballinger","year":"2019","unstructured":"Ballinger, E.C. et al. Mecp2 deletion from cholinergic neurons selectively impairs recognition memory and disrupts cholinergic modulation of the perirhinal cortex. eNeuro 6, ENEURO.0134-19.2019 (2019).","journal-title":"eNeuro"},{"key":"568_CR104","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.neuron.2008.07.030","volume":"59","author":"SL Fyffe","year":"2008","unstructured":"Fyffe, S. L. et al. Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59, 947\u2013958 (2008).","journal-title":"Neuron"},{"key":"568_CR105","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64833","volume":"10","author":"NP Achilly","year":"2021","unstructured":"Achilly, N. P. et al. Deleting Mecp2 from the cerebellum rather than its neuronal subtypes causes a delay in motor learning in mice. Elife 10, e64833 (2021).","journal-title":"Elife"},{"key":"568_CR106","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1523\/JNEUROSCI.4624-14.2015","volume":"35","author":"SH Su","year":"2015","unstructured":"Su, S. H., Kao, F. C., Huang, Y. B. & Liao, W. MeCP2 in the rostral striatum maintains local dopamine content critical for psychomotor control. J. Neurosci. 35, 6209\u20136220 (2015).","journal-title":"J. Neurosci."},{"key":"568_CR107","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.biopsych.2005.07.025","volume":"59","author":"T Gemelli","year":"2006","unstructured":"Gemelli, T. et al. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol. Psychiatry 59, 468\u2013476 (2006).","journal-title":"Biol. Psychiatry"},{"key":"568_CR108","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2016.05.033","volume":"166","author":"LL Orefice","year":"2016","unstructured":"Orefice, L. L. et al. Peripheral mechanosensory neuron dysfunction underlies tactile and behavioral deficits in mouse models of ASDs. Cell 166, 299\u2013313 (2016).","journal-title":"Cell"},{"key":"568_CR109","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nature09582","volume":"468","author":"HT Chao","year":"2010","unstructured":"Chao, H. T. et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468, 263\u2013269 (2010).","journal-title":"Nature"},{"key":"568_CR110","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14199","volume":"5","author":"X Meng","year":"2016","unstructured":"Meng, X. et al. Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders. eLife 5, e14199 (2016).","journal-title":"eLife"},{"key":"568_CR111","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14198","volume":"5","author":"K Ure","year":"2016","unstructured":"Ure, K. et al. Restoration of Mecp2 expression in GABAergic neurons is sufficient to rescue multiple disease features in a mouse model of Rett syndrome. eLife 5, e14198 (2016).","journal-title":"eLife"},{"key":"568_CR112","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ar.21380","volume":"294","author":"ME Blue","year":"2011","unstructured":"Blue, M. E. et al. Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice. Anat. Rec. 294, 1624\u20131634 (2011).","journal-title":"Anat. Rec."},{"key":"568_CR113","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1531-8249(199904)45:4<541::AID-ANA21>3.0.CO;2-2","volume":"45","author":"ME Blue","year":"1999","unstructured":"Blue, M. E., Naidu, S. & Johnston, M. V. Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann. Neurol. 45, 541\u2013545 (1999).","journal-title":"Ann. Neurol."},{"key":"568_CR114","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1053\/ejpn.2002.0612","volume":"6","author":"B Hagberg","year":"2002","unstructured":"Hagberg, B., Hanefeld, F., Percy, A. & Skjeldal, O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett syndrome clinical criteria consensus panel satellite to european paediatric neurology society meeting, Baden Baden, Germany, 11 September 2001. Eur. J. Paediatr. Neurol. 6, 293\u2013297 (2002).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"568_CR115","doi-asserted-by":"publisher","first-page":"253","DOI":"10.31887\/DCNS.2012.14.3\/jneul","volume":"14","author":"JL Neul","year":"2012","unstructured":"Neul, J. L. The relationship of Rett syndrome and MECP2 disorders to autism. Dialogues Clin. Neurosci. 14, 253\u2013262 (2012).","journal-title":"Dialogues Clin. Neurosci."},{"key":"568_CR116","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.pediatrneurol.2015.02.007","volume":"52","author":"DC Tarquinio","year":"2015","unstructured":"Tarquinio, D. C. et al. Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosis. Pediatr. Neurol. 52, 585\u2013591.e2 (2015).","journal-title":"Pediatr. Neurol."},{"key":"568_CR117","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/cells12101437","volume":"12","author":"E Frankel","year":"2023","unstructured":"Frankel, E. et al. Genetic and protein network underlying the convergence of Rett-syndrome-like (RTT-L) phenotype in neurodevelopmental disorders. Cells 12, 1437 (2023).","journal-title":"Cells"},{"key":"568_CR118","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajmg.a.36416","volume":"164a","author":"WH Tan","year":"2014","unstructured":"Tan, W. H., Bird, L. M., Thibert, R. L. & Williams, C. A. If not Angelman, what is it? A review of Angelman-like syndromes. Am. J. Med. Genet. A 164a, 975\u2013992 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"568_CR119","doi-asserted-by":"publisher","unstructured":"Spagnoli, C., Fusco, C. & Pisani, F. Rett syndrome spectrum in monogenic developmental-epileptic encephalopathies and epilepsies: a review. Genes 12, https:\/\/doi.org\/10.3390\/genes12081157 (2021).","DOI":"10.3390\/genes12081157"},{"key":"568_CR120","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.3390\/ijms20163925","volume":"20","author":"S Vidal","year":"2019","unstructured":"Vidal, S. et al. Genetic landscape of Rett syndrome spectrum: improvements and challenges. Int. J. Mol. Sci. 20, 3925 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"568_CR121","doi-asserted-by":"publisher","first-page":"10374","DOI":"10.3390\/ijms221910375","volume":"22","author":"C Xiol","year":"2021","unstructured":"Xiol, C., Heredia, M., Pascual-Alonso, A., Oyarzabal, A. & Armstrong, J. Technological improvements in the genetic diagnosis of Rett syndrome spectrum disorders. Int. J. Mol. Sci. 22, 10374 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"568_CR122","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1212\/WNL.0b013e31826e9a70","volume":"79","author":"DC Tarquinio","year":"2012","unstructured":"Tarquinio, D. C. et al. Growth failure and outcome in Rett syndrome: specific growth references. Neurology 79, 1653\u20131661 (2012).","journal-title":"Neurology"},{"key":"568_CR123","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0733-8619(18)30341-4","volume":"8","author":"A Percy","year":"1990","unstructured":"Percy, A., Gillberg, C., Hagberg, B. & Witt-Engerstr\u00f6m, I. Rett syndrome and the autistic disorders. Neurol. Clin. 8, 659\u2013676 (1990).","journal-title":"Neurol. Clin."},{"key":"568_CR124","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/archneurol.2011.149","volume":"68","author":"AK Percy","year":"2011","unstructured":"Percy, A. K. Rett syndrome: exploring the autism link. Arch. Neurol. 68, 985\u2013989 (2011).","journal-title":"Arch. Neurol."},{"key":"568_CR125","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/brain\/aww302","volume":"140","author":"DC Tarquinio","year":"2017","unstructured":"Tarquinio, D. C. et al. Longitudinal course of epilepsy in Rett syndrome and related disorders. Brain 140, 306\u2013318 (2017).","journal-title":"Brain"},{"key":"568_CR126","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.braindev.2018.03.010","volume":"40","author":"DC Tarquinio","year":"2018","unstructured":"Tarquinio, D. C. et al. The course of awake breathing disturbances across the lifespan in Rett syndrome. Brain Dev. 40, 515\u2013529 (2018).","journal-title":"Brain Dev."},{"key":"568_CR127","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/YCO.0000000000000389","volume":"31","author":"F Ehrhart","year":"2018","unstructured":"Ehrhart, F., Sangani, N. B. & Curfs, L. M. G. Current developments in the genetics of Rett and Rett-like syndrome. Curr. Opin. Psychiatry 31, 103\u2013108 (2018).","journal-title":"Curr. Opin. Psychiatry"},{"issue":"Suppl 1","key":"568_CR128","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.braindev.2005.03.018","volume":"27","author":"SS Budden","year":"2005","unstructured":"Budden, S. S., Dorsey, H. C. & Steiner, R. D. Clinical profile of a male with Rett syndrome. Brain Dev. 27 (Suppl. 1), S69\u2013s71 (2005).","journal-title":"Brain Dev."},{"key":"568_CR129","volume":"10","author":"G Chahil","year":"2018","unstructured":"Chahil, G., Yelam, A. & Bollu, P. C. Rett syndrome in males: a case report and review of literature. Cureus 10, e3414 (2018).","journal-title":"Cureus"},{"key":"568_CR130","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2007-979729","volume":"26","author":"HJ Christen","year":"1995","unstructured":"Christen, H. J. & Hanefeld, F. Male Rett variant. Neuropediatrics 26, 81\u201382 (1995).","journal-title":"Neuropediatrics"},{"key":"568_CR131","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1055\/s-2006-924613","volume":"37","author":"M Lundvall","year":"2006","unstructured":"Lundvall, M., Samuelsson, L. & Kyllerman, M. Male Rett phenotypes in T158M and R294X MeCP2-mutations. Neuropediatrics 37, 296\u2013301 (2006).","journal-title":"Neuropediatrics"},{"key":"568_CR132","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cns3.20038","volume":"1","author":"JL Neul","year":"2023","unstructured":"Neul, J. L. et al. Distribution of hand function by age in individuals with Rett syndrome. Ann. Child. Neurol. Soc. 1, 228\u2013238 (2023).","journal-title":"Ann. Child. Neurol. Soc."},{"key":"568_CR133","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.3390\/ijerph16173075","volume":"16","author":"MB Pitzianti","year":"2019","unstructured":"Pitzianti, M. B., Santamaria Palombo, A., Esposito, S. & Pasini, A. Rett syndrome in males: the different clinical course in two brothers with the same microduplication MECP2 Xq28. Int. J. Environ. Res. Public Health 16, 3075 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"568_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02500-5","volume":"21","author":"J Shah","year":"2021","unstructured":"Shah, J., Patel, H., Jain, D., Sheth, F. & Sheth, H. A rare case of a male child with post-zygotic de novo mosaic variant c.538C\u2009>\u2009T in MECP2 gene: a case report of Rett syndrome. BMC Neurol. 21, 469 (2021).","journal-title":"BMC Neurol."},{"key":"568_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.532","volume":"7","author":"JA Yoon","year":"2019","unstructured":"Yoon, J. A., Yoo, Y., Lee, J. S., Kim, Y. M. & Shin, Y. B. An early seizure variant type of a male Rett syndrome patient with a MECP2 p.Arg133His missense mutation. Mol. Genet. Genom. Med. 7, e532 (2019).","journal-title":"Mol. Genet. Genom. Med."},{"key":"568_CR136","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/hmg\/9.9.1377","volume":"9","author":"T Bienvenu","year":"2000","unstructured":"Bienvenu, T. et al. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum. Mol. Genet. 9, 1377\u20131384 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"568_CR137","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/hmg\/9.9.1369","volume":"9","author":"P Huppke","year":"2000","unstructured":"Huppke, P., Laccone, F., Kr\u00e4mer, N., Engel, W. & Hanefeld, F. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum. Mol. Genet. 9, 1369\u20131375 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"568_CR138","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/humu.10243","volume":"22","author":"G Miltenberger-Miltenyi","year":"2003","unstructured":"Miltenberger-Miltenyi, G. & Laccone, F. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum. Mutat. 22, 107\u2013115 (2003).","journal-title":"Hum. Mutat."},{"key":"568_CR139","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1086\/320109","volume":"68","author":"R Trappe","year":"2001","unstructured":"Trappe, R. et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am. J. Hum. Genet. 68, 1093\u20131101 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"568_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02846-2","volume":"21","author":"Y Wen","year":"2023","unstructured":"Wen, Y. et al. MECP2 germline mosaicism plays an important part in the inheritance of Rett syndrome: a study of MECP2 germline mosaicism in males. BMC Med. 21, 155 (2023).","journal-title":"BMC Med."},{"key":"568_CR141","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/0883073807307077","volume":"23","author":"B Xinhua","year":"2008","unstructured":"Xinhua, B. et al. X chromosome inactivation in Rett syndrome and its correlations with MECP2 mutations and phenotype. J. Child. Neurol. 23, 22\u201325 (2008).","journal-title":"J. Child. Neurol."},{"key":"568_CR142","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11689-009-9034-7","volume":"1","author":"K Augenstein","year":"2009","unstructured":"Augenstein, K., Lane, J. B., Horton, A., Schanen, C. & Percy, A. K. Variable phenotypic expression of a MECP2 mutation in a family. J. Neurodev. Disord. 1, 313 (2009).","journal-title":"J. Neurodev. Disord."},{"key":"568_CR143","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/088307389801300507","volume":"13","author":"NC Schanen","year":"1998","unstructured":"Schanen, N. C. et al. Neonatal encephalopathy in two boys in families with recurrent Rett syndrome. J. Child. Neurol. 13, 229\u2013231 (1998).","journal-title":"J. Child. Neurol."},{"key":"568_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02240-w","volume":"17","author":"H Leonard","year":"2022","unstructured":"Leonard, H. et al. Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome. Orphanet J. Rare Dis. 17, 108 (2022).","journal-title":"Orphanet J. Rare Dis."},{"key":"568_CR145","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2174\/15748847113086660069","volume":"8","author":"CA Chapleau","year":"2013","unstructured":"Chapleau, C. A., Lane, J., Pozzo-Miller, L. & Percy, A. K. Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives. Curr. Clin. Pharmacol. 8, 358\u2013369 (2013).","journal-title":"Curr. Clin. Pharmacol."},{"key":"568_CR146","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1100\/tsw.2006.187","volume":"6","author":"M Lotan","year":"2006","unstructured":"Lotan, M. & Hanks, S. Physical therapy intervention for individuals with Rett syndrome. ScientificWorldJournal 6, 1314\u20131338 (2006).","journal-title":"ScientificWorldJournal"},{"key":"568_CR147","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40265-023-01883-8","volume":"83","author":"SJ Keam","year":"2023","unstructured":"Keam, S. J. Trofinetide: first approval. Drugs 83, 819\u2013824 (2023).","journal-title":"Drugs"},{"key":"568_CR148","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.tips.2023.06.008","volume":"44","author":"H Parent","year":"2023","unstructured":"Parent, H., Ferranti, A. & Niswender, C. Trofinetide: a pioneering treatment for Rett syndrome. Trends Pharmacol. Sci. 44, 740\u2013741 (2023).","journal-title":"Trends Pharmacol. Sci."},{"key":"568_CR149","doi-asserted-by":"publisher","first-page":"e1912","DOI":"10.1212\/WNL.0000000000007316","volume":"92","author":"DG Glaze","year":"2019","unstructured":"Glaze, D. G. et al. Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome. Neurology 92, e1912\u2013e1925 (2019).","journal-title":"Neurology"},{"key":"568_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678707.2023.2217328","volume":"11","author":"ED Marsh","year":"2023","unstructured":"Marsh, E. D. et al. Recommendations for the management of diarrhea with trofinetide use in Rett syndrome. Expert. Opin. Orphan Drugs 11, 1\u20138 (2023).","journal-title":"Expert. Opin. Orphan Drugs"},{"key":"568_CR151","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s12325-024-02782-4","volume":"41","author":"R Moore","year":"2024","unstructured":"Moore, R. et al. Managing gastrointestinal symptoms resulting from treatment with trofinetide for Rett syndrome: caregiver and nurse perspectives. Adv. Ther. 41, 1305\u20131317 (2024).","journal-title":"Adv. Ther."},{"key":"568_CR152","doi-asserted-by":"crossref","unstructured":"Trofinetide (Daybue) for Rett syndrome. Med. Lett. Drugs Ther. 66, e115\u2013e116 (2024).","DOI":"10.58347\/tml.2024.1706d"},{"key":"568_CR153","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mrdd.10020","volume":"8","author":"B Hagberg","year":"2002","unstructured":"Hagberg, B. Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8, 61\u201365 (2002).","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"568_CR154","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/MPG.0000000000000200","volume":"58","author":"G Baikie","year":"2014","unstructured":"Baikie, G. et al. Gastrointestinal dysmotility in Rett syndrome. J. Pediatr. Gastroenterol. Nutr. 58, 237\u2013244 (2014).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"568_CR155","doi-asserted-by":"publisher","first-page":"E607","DOI":"10.1097\/BRS.0b013e3181a95ca4","volume":"34","author":"J Downs","year":"2009","unstructured":"Downs, J. et al. Guidelines for management of scoliosis in Rett syndrome patients based on expert consensus and clinical evidence. Spine 34, E607\u2013E617 (2009).","journal-title":"Spine"},{"key":"568_CR156","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/dmcn.12358","volume":"56","author":"M Freilinger","year":"2014","unstructured":"Freilinger, M. et al. Prevalence, clinical investigation, and management of gallbladder disease in Rett syndrome. Dev. Med. Child. Neurol. 56, 756\u2013762 (2014).","journal-title":"Dev. Med. Child. Neurol."},{"key":"568_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146824","volume":"11","author":"A Jefferson","year":"2016","unstructured":"Jefferson, A. et al. Clinical guidelines for management of bone health in Rett syndrome based on expert consensus and available evidence. PLoS ONE 11, e0146824 (2016).","journal-title":"PLoS ONE"},{"key":"568_CR158","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/MPG.0b013e31829e0b65","volume":"57","author":"H Leonard","year":"2013","unstructured":"Leonard, H. et al. Assessment and management of nutrition and growth in Rett syndrome. J. Pediatr. Gastroenterol. Nutr. 57, 451\u2013460 (2013).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"568_CR159","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/07434618.2020.1785009","volume":"36","author":"GS Townend","year":"2020","unstructured":"Townend, G. S., Bartolotta, T. E., Urbanowicz, A., Wandin, H. & Curfs, L. M. G. Development of consensus-based guidelines for managing communication of individuals with Rett syndrome. Augment. Altern. Commun. 36, 71\u201381 (2020).","journal-title":"Augment. Altern. Commun."},{"key":"568_CR160","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s11689-023-09502-z","volume":"15","author":"JL Neul","year":"2023","unstructured":"Neul, J. L. et al. Top caregiver concerns in Rett syndrome and related disorders: data from the US Natural History Study. J. Neurodev. Disord. 15, 33 (2023).","journal-title":"J. Neurodev. Disord."},{"key":"568_CR161","unstructured":"International Rett Syndrome Foundation. Care and development. International Rett Syndrome Foundation www.rettsyndrome.org\/for-families\/living-with-rett\/care-development\/ (2024)."},{"key":"568_CR162","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MPG.0b013e31824b6159","volume":"55","author":"KJ Motil","year":"2012","unstructured":"Motil, K. J. et al. Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome. J. Pediatr. Gastroenterol. Nutr. 55, 292\u2013298 (2012).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"568_CR163","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1203\/PDR.0b013e318180ebcd","volume":"64","author":"KJ Motil","year":"2008","unstructured":"Motil, K. J., Ellis, K. J., Barrish, J. O., Caeg, E. & Glaze, D. G. Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome. Pediatr. Res. 64, 435\u2013439 (2008).","journal-title":"Pediatr. Res."},{"key":"568_CR164","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.pediatrneurol.2014.08.013","volume":"51","author":"JT Killian","year":"2014","unstructured":"Killian, J. T. et al. Pubertal development in Rett syndrome deviates from typical females. Pediatr. Neurol. 51, 769\u2013775 (2014).","journal-title":"Pediatr. Neurol."},{"key":"568_CR165","volume":"13","author":"B Rocos","year":"2021","unstructured":"Rocos, B. & Zeller, R. Correcting scoliosis in Rett syndrome. Cureus 13, e15411 (2021).","journal-title":"Cureus"},{"key":"568_CR166","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/jmedgenet-2020-107333","volume":"59","author":"A Peron","year":"2022","unstructured":"Peron, A. et al. Phenotypes in adult patients with Rett syndrome: results of a 13-year experience and insights into healthcare transition. J. Med. Genet. 59, 39\u201345 (2022).","journal-title":"J. Med. Genet."},{"key":"568_CR167","doi-asserted-by":"publisher","first-page":"817195","DOI":"10.3389\/fneur.2022.817195","volume":"13","author":"G Tascini","year":"2022","unstructured":"Tascini, G. et al. Sleep disorders in Rett syndrome and Rett-related disorders: a narrative review. Front. Neurol. 13, 817195 (2022).","journal-title":"Front. Neurol."},{"key":"568_CR168","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/jir.12834","volume":"65","author":"YYL Lai","year":"2021","unstructured":"Lai, Y. Y. L. et al. Oral health care and service utilisation in individuals with Rett syndrome: an international cross-sectional study. J. Intellect. Disabil. Res. 65, 561\u2013576 (2021).","journal-title":"J. Intellect. Disabil. Res."},{"key":"568_CR169","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.3390\/ijerph17124466","volume":"17","author":"J G\u00fceita-Rodriguez","year":"2020","unstructured":"G\u00fceita-Rodriguez, J. et al. Challenges affecting access to health and social care resources and time management among parents of children with Rett syndrome: a qualitative case study. Int. J. Environ. Res. Public. Health 17, 4466 (2020).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"568_CR170","first-page":"153","volume":"19","author":"Y Kodra","year":"2007","unstructured":"Kodra, Y. et al. Access to and quality of health and social care for rare diseases: patients\u2019 and caregivers\u2019 experiences. Ann. Ig. 19, 153\u2013160 (2007).","journal-title":"Ann. Ig."},{"key":"568_CR171","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/dmcn.15033","volume":"64","author":"A Binagwaho","year":"2022","unstructured":"Binagwaho, A. & Muvunyi, R. Overcoming the barriers to care for children with neurodevelopmental disorders. Dev. Med. Child. Neurol. 64, 12 (2022).","journal-title":"Dev. Med. Child. Neurol."},{"key":"568_CR172","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/09638288.2012.715720","volume":"35","author":"F Lim","year":"2013","unstructured":"Lim, F., Downs, J., Li, J., Bao, X. H. & Leonard, H. Caring for a child with severe intellectual disability in China: the example of Rett syndrome. Disabil. Rehabil. 35, 343\u2013351 (2013).","journal-title":"Disabil. Rehabil."},{"key":"568_CR173","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1212\/WNL.0b013e3182377dd2","volume":"77","author":"JB Lane","year":"2011","unstructured":"Lane, J. B. et al. Clinical severity and quality of life in children and adolescents with Rett syndrome. Neurology 77, 1812\u20131818 (2011).","journal-title":"Neurology"},{"key":"568_CR174","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jmedgenet-2020-107120","volume":"58","author":"J Mendoza","year":"2021","unstructured":"Mendoza, J., Downs, J., Wong, K. & Leonard, H. Determinants of quality of life in Rett syndrome: new findings on associations with genotype. J. Med. Genet. 58, 637\u2013644 (2021).","journal-title":"J. Med. Genet."},{"key":"568_CR175","first-page":"6302","volume":"8","author":"L Parisi","year":"2016","unstructured":"Parisi, L., Di Filippo, T. & Roccella, M. The quality of life in girls with Rett syndrome. Ment. Illn. 8, 6302 (2016).","journal-title":"Ment. Illn."},{"key":"568_CR176","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1007\/s10803-015-2457-y","volume":"45","author":"R Cianfaglione","year":"2015","unstructured":"Cianfaglione, R., Hastings, R. P., Felce, D., Clarke, A. & Kerr, M. P. Psychological well-being of mothers and siblings in families of girls and women with Rett syndrome. J. Autism Dev. Disord. 45, 2939\u20132946 (2015).","journal-title":"J. Autism Dev. Disord."},{"key":"568_CR177","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2015.12.021","volume":"58","author":"JT Killian Jr","year":"2016","unstructured":"Killian, J. T. Jr et al. Caretaker quality of life in Rett syndrome: disorder features and psychological predictors. Pediatr. Neurol. 58, 67\u201374 (2016).","journal-title":"Pediatr. Neurol."},{"key":"568_CR178","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00787-018-1214-0","volume":"28","author":"Y Mori","year":"2019","unstructured":"Mori, Y., Downs, J., Wong, K. & Leonard, H. Longitudinal effects of caregiving on parental well-being: the example of Rett syndrome, a severe neurological disorder. Eur. Child. Adolesc. Psychiatry 28, 505\u2013520 (2019).","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"568_CR179","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s10803-017-3420-x","volume":"48","author":"Y Mori","year":"2018","unstructured":"Mori, Y., Downs, J., Wong, K., Heyworth, J. & Leonard, H. Comparing parental well-being and its determinants across three different genetic disorders causing intellectual disability. J. Autism Dev. Disord. 48, 1651\u20131665 (2018).","journal-title":"J. Autism Dev. Disord."},{"key":"568_CR180","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/ijerph16010041","volume":"16","author":"D Palacios-Ce\u00f1a","year":"2019","unstructured":"Palacios-Ce\u00f1a, D. et al. \u201cLiving an Obstacle Course\u201d: a qualitative study examining the experiences of caregivers of children with Rett syndrome. Int. J. Environ. Res. Public Health 16, 41 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"568_CR181","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2298\/VSP1309842S","volume":"70","author":"A Sarajlija","year":"2013","unstructured":"Sarajlija, A., Djuri\u0107, M. & Tepavcevi\u0107, D. K. Health-related quality of life and depression in Rett syndrome caregivers. Vojnosanit. Pregl. 70, 842\u2013847 (2013).","journal-title":"Vojnosanit. Pregl."},{"key":"568_CR182","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2788.2007.01005.x","volume":"52","author":"S Mulroy","year":"2008","unstructured":"Mulroy, S., Robertson, L., Aiberti, K., Leonard, H. & Bower, C. The impact of having a sibling with an intellectual disability: parental perspectives in two disorders. J. Intellect. Disabil. Res. 52, 216\u2013229 (2008).","journal-title":"J. Intellect. Disabil. Res."},{"key":"568_CR183","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13023-024-03313-8","volume":"19","author":"WE Kaufmann","year":"2024","unstructured":"Kaufmann, W. E. et al. Burden of illness in Rett syndrome: initial evaluation of a disorder-specific caregiver survey. Orphanet J. Rare Dis. 19, 296 (2024).","journal-title":"Orphanet J. Rare Dis."},{"key":"568_CR184","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11136-018-2057-3","volume":"28","author":"J Downs","year":"2019","unstructured":"Downs, J. et al. Psychometric properties of the Quality of Life Inventory-Disability (QI-Disability) measure. Qual. Life Res. 28, 783\u2013794 (2019).","journal-title":"Qual. Life Res."},{"key":"568_CR185","doi-asserted-by":"publisher","first-page":"104322","DOI":"10.1016\/j.ridd.2022.104322","volume":"129","author":"H Leonard","year":"2022","unstructured":"Leonard, H. et al. Quality of life beyond diagnosis in intellectual disability \u2013 latent profiling. Res. Dev. Disabil. 129, 104322 (2022).","journal-title":"Res. Dev. Disabil."},{"key":"568_CR186","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ajmg.a.37500","volume":"170","author":"A Epstein","year":"2016","unstructured":"Epstein, A. et al. Conceptualizing with Rett syndrome using qualitative methods. Am. J. Med. Genet. A 170, 645\u2013653 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"568_CR187","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1080\/09638288.2019.1610801","volume":"42","author":"A Strugnell","year":"2020","unstructured":"Strugnell, A., Leonard, H., Epstein, A. & Downs, J. Using directed-content analysis to identify a framework for understanding quality of life in adults with Rett syndrome. Disabil. Rehabil. 42, 3800\u20133807 (2020).","journal-title":"Disabil. Rehabil."},{"key":"568_CR188","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/426462","volume":"75","author":"LS Weaving","year":"2004","unstructured":"Weaving, L. S. et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet. 75, 1079\u20131093 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"568_CR189","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajhg.2008.05.015","volume":"83","author":"F Ariani","year":"2008","unstructured":"Ariani, F. et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am. J. Hum. Genet. 83, 89\u201393 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"568_CR190","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05606614 (2024)."},{"key":"568_CR191","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05898620 (2024)."},{"key":"568_CR192","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06152237 (2024)."},{"key":"568_CR193","doi-asserted-by":"publisher","first-page":"1172805","DOI":"10.3389\/fnins.2023.1172805","volume":"17","author":"M Palmieri","year":"2023","unstructured":"Palmieri, M., Pozzer, D. & Landsberger, N. Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives. Front. Neurosci. 17, 1172805 (2023).","journal-title":"Front. Neurosci."},{"key":"568_CR194","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/dmcn.15383","volume":"65","author":"N Panayotis","year":"2023","unstructured":"Panayotis, N., Ehinger, Y., Felix, M. S. & Roux, J. C. State-of-the-art therapies for Rett syndrome. Dev. Med. Child. Neurol. 65, 162\u2013170 (2023).","journal-title":"Dev. Med. Child. Neurol."},{"key":"568_CR195","first-page":"187","volume":"4","author":"WE Kaufmann","year":"1998","unstructured":"Kaufmann, W. E., Pearlson, G. D. & Naidu, S. The neuroanatomy of Rett syndrome: neuropathological and neuroimaging studies. Riv. Med. 4, 187\u2013199 (1998).","journal-title":"Riv. Med."},{"key":"568_CR196","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.tig.2022.01.007","volume":"38","author":"NB Grimm","year":"2022","unstructured":"Grimm, N. B. & Lee, J. T. Selective Xi reactivation and alternative methods to restore MECP2 function in Rett syndrome. Trends Genet. 38, 920\u2013943 (2022).","journal-title":"Trends Genet."},{"key":"568_CR197","doi-asserted-by":"publisher","unstructured":"Jagadeeswaran, I., Oh, J. & Sinnett, S. E. Preclinical milestones in MECP2 gene transfer for treating Rett syndrome. Dev. Neurosci. https:\/\/doi.org\/10.1159\/000539267 (2024).","DOI":"10.1159\/000539267"},{"key":"568_CR198","doi-asserted-by":"publisher","first-page":"146644","DOI":"10.1016\/j.brainres.2019.146644","volume":"1729","author":"MC Ribeiro","year":"2020","unstructured":"Ribeiro, M. C. & MacDonald, J. L. Sex differences in Mecp2-mutant Rett syndrome model mice and the impact of cellular mosaicism in phenotype development. Brain Res. 1729, 146644 (2020).","journal-title":"Brain Res."},{"key":"568_CR199","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/hmg\/ddv496","volume":"25","author":"K Brown","year":"2016","unstructured":"Brown, K. et al. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome. Hum. Mol. Genet. 25, 558\u2013570 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"568_CR200","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/hmg\/dds406","volume":"22","author":"RC Samaco","year":"2013","unstructured":"Samaco, R. C. et al. Female Mecp2+\/\u2212 mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum. Mol. Genet. 22, 96\u2013109 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"568_CR201","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.3390\/ijms22073751","volume":"22","author":"AR Gomes","year":"2021","unstructured":"Gomes, A. R., Fernandes, T. G., Cabral, J. M. S. & Diogo, M. M. Modeling Rett syndrome with human pluripotent stem cells: mechanistic outcomes and future clinical perspectives. Int. J. Mol. Sci. 22, 3751 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"568_CR202","doi-asserted-by":"publisher","first-page":"698812","DOI":"10.3389\/fnins.2021.698812","volume":"15","author":"FD Haase","year":"2021","unstructured":"Haase, F. D. et al. Pre-clinical investigation of Rett syndrome using human stem cell-based disease models. Front. Neurosci. 15, 698812 (2021).","journal-title":"Front. Neurosci."},{"key":"568_CR203","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0387-7604(85)80037-1","volume":"7","author":"F Hanefeld","year":"1985","unstructured":"Hanefeld, F. The clinical pattern of the Rett syndrome. Brain Dev. 7, 320\u2013325 (1985).","journal-title":"Brain Dev."},{"key":"568_CR204","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0387-7604(85)80030-9","volume":"7","author":"S Rolando","year":"1985","unstructured":"Rolando, S. Rett syndrome: report of eight cases. Brain Dev. 7, 290\u2013296 (1985).","journal-title":"Brain Dev."},{"key":"568_CR205","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1086\/426460","volume":"75","author":"J Tao","year":"2004","unstructured":"Tao, J. et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5\/STK9) gene are associated with severe neurodevelopmental retardation. Am. J. Hum. Genet. 75, 1149\u20131154 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"568_CR206","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ana.25797","volume":"88","author":"C Cutri-French","year":"2020","unstructured":"Cutri-French, C. et al. Comparison of core features in four developmental encephalopathies in the Rett Natural History Study. Ann. Neurol. 88, 396\u2013406 (2020).","journal-title":"Ann. Neurol."}],"updated-by":[{"DOI":"10.1038\/s41572-025-00610-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000}}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-024-00568-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-024-00568-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-024-00568-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T14:37:52Z","timestamp":1742999872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-024-00568-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":206,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1038\/s41572-024-00568-0","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"2 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41572-025-00610-9","URL":"https:\/\/doi.org\/10.1038\/s41572-025-00610-9","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.K.P. has a consulting relationship with Acadia Pharmaceuticals, Anavex, Ionis, Neurogene, and Taysha, and has previously had a contract researcher relationship with Acadia Pharmaceuticals. J.L.N. has received research funding from the National Institutes of Health, the International Rett Syndrome Foundation and the Rett Syndrome Research Trust, and has served as investigator for clinical trials conducted by Acadia Pharmaceuticals, GW Pharmaceuticals, Neuren Pharmaceuticals and Newron. J.L.N. has also received personal consultancy for Acadia Pharmaceuticals Inc., Analysis Group, Anavex, AveXis, GW Pharmaceuticals, Hoffmann-La Roche, Ionis Pharmaceuticals, Myrtelle, Neurogene, Newron Pharmaceuticals, Signant Health and Taysha Gene Therapies, and the preparation of CME activities for the France Foundation, MedEdicus, Medscape, PeerView Institute, Medscape and TotalCME; and served on the scientific advisory board of Alcyone Lifesciences; was a scientific cofounder of LizarBio Therapeutics; and is\u00a0a member of a data safety monitoring board for clinical trials conducted by Ovid Therapeutics and Ultragenix. S.R.C. is currently the Chief Scientific Officer at Neurogene Inc. He received research funding from the Rett Syndrome Research Trust, Simons Initiative for the Developing Brain, Neurogene and Rettco Inc. He has received patent royalties relating to gene therapy products being developed for Rett syndrome. B.B.-Z. received research funding for clinical trials from Ultragenix and the Rett Syndrome Research Trust. She has been a consultant to Taysha in the past and is serving as a monitor for Neurogene gene therapy programme. A.V. is a consultant for Anavex and GW Pharmaceuticals, and has conducted clinical trials with Newron Pharmaceuticals. L.P.-M. has received research funding from the National Institutes of Health, the International Rett Syndrome Foundation, and the Rett Syndrome Research Trust. W.E.K. was the Chief Scientific Officer of Anavex Life Sciences Corp. He received funding from the International Rett Syndrome Foundation, the National Institutes of Health and the Centers for Disease Control and Prevention, and he has been a consultant for Anavex, AveXis, Acadia, Compass, EryDel\/Quince, Neuren Pharmaceuticals, Newron, GW Pharmaceuticals, Marinus, Biohaven, Zynerba, Ovid Therapeutics, Stalicla and Tetra. He has conducted clinical trials with Neuren and Ipsen. W.A.G sits on the Scientific Advisory Board of the International Rett Syndrome Foundation and has received funding from the Australian National Health and Medical Research Council. J.K.I. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}